Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry.


Journal

Thrombosis research
ISSN: 1879-2472
Titre abrégé: Thromb Res
Pays: United States
ID NLM: 0326377

Informations de publication

Date de publication:
02 2021
Historique:
received: 08 09 2020
revised: 20 10 2020
accepted: 18 11 2020
pubmed: 3 12 2020
medline: 22 6 2021
entrez: 2 12 2020
Statut: ppublish

Résumé

There is a paucity of data on the influence of low body weight on clinical outcomes in patients with acute venous thromboembolism (VTE). The COMMAND VTE registry is a multicenter cohort study enrolling 3027 consecutive patients with acute symptomatic VTE. The current study population consisted of 2778 patients with available body weight value, who were divided into 2 groups; 1705 patients with lower body weight (≤60 kg) and 1073 patients with higher body weight (>60 kg). Patients with lower body weight were older (70.8 versus 60.9 years, P < 0.001), and more often women (75% versus 38%, P < 0.001), and more often had active cancer (27% versus 19%, P < 0.001) than those with higher body weight. The cumulative 5-year incidence of recurrent VTE was not significantly different between the 2 groups (10.6% versus 10.7%, P = 0.51). The cumulative 5-year incidences of major bleeding and all-cause death were significantly higher in patients with lower body weight than in those with higher body weight (14.6% versus 9.6%, P < 0.001, and 35.8% versus 19.8%, P < 0.001, respectively). The excess adjusted risk of patients with lower body weight relative to those with higher body weight remained significant for major bleeding and all-cause death (HR 1.57, 95%CI: 1.16-2.12, P = 0.003, and HR 1.50, 95%CI: 1.24-1.81, P < 0.001, respectively). In the current Japanese real-world registry, there were a high proportion of patients with low body weight, who had a higher risk for major bleeding and mortality without significant excess risk for recurrent VTE.

Identifiants

pubmed: 33264736
pii: S0049-3848(20)30629-0
doi: 10.1016/j.thromres.2020.11.022
pii:
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

26-33

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Kazuhisa Kaneda (K)

Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan.

Yugo Yamashita (Y)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Electronic address: yyamashi@kuhp.kyoto-u.ac.jp.

Takeshi Morimoto (T)

Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan.

Hideo Amano (H)

Department of Cardiovascular Medicine, Kurashiki Central Hospital, Kurashiki, Japan.

Toru Takase (T)

Department of Cardiology, Kinki University Hospital, Osaka, Japan.

Seiich Hiramori (S)

Department of Cardiology, Kokura Memorial Hospital, Kokura, Japan.

Kitae Kim (K)

Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.

Maki Oi (M)

Department of Cardiology, Japanese Red Cross Otsu Hospital, Otsu, Japan.

Masaharu Akao (M)

Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Yohei Kobayashi (Y)

Department of Cardiovascular Center, Osaka Red Cross Hospital, Osaka, Japan.

Mamoru Toyofuku (M)

Department of Cardiology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.

Yusuke Morita (Y)

Cardiovascular Center, The Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan.

Tomohisa Tada (T)

Department of Cardiology, Shizuoka General Hospital, Shizuoka, Japan.

Po-Min Chen (PM)

Department of Cardiology, Saiseikai Noe Hospital, Osaka, Japan.

Koichiro Murata (K)

Department of Cardiology, Shizuoka City Shizuoka Hospital, Shizuoka, Japan.

Yoshiaki Tsuyuki (Y)

Division of Cardiology, Shimada Municipal Hospital, Shimada, Japan.

Yoshihisa Nakagawa (Y)

Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan.

Yuji Nishimoto (Y)

Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.

Syunsuke Saga (S)

Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.

Jiro Sakamoto (J)

Department of Cardiology, Tenri Hospital, Tenri, Japan.

Minako Kinoshita (M)

Department of Cardiology, Nishi Kobe Medical Center, Kobe, Japan.

Kiyonori Togi (K)

Division of Cardiology, Nara Hospital, Kinki University Faculty of Medicine, Ikoma, Japan.

Katsuhisa Ishii (K)

Department of Cardiology, Kansai Denryoku Hospital, Osaka, Japan.

Hiroshi Mabuchi (H)

Department of Cardiology, Koto Memorial Hospital, Higashiomi, Japan.

Kensuke Takabayashi (K)

Department of Cardiology, Hirakata Kohsai Hospital, Hirakata, Japan.

Shun Hojo (S)

Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan.

Tetsuma Kawaji (T)

Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan.

Akihiro Kushiyama (A)

Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan.

Hidenori Yaku (H)

Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan.

Kenji Nakatsuma (K)

Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan.

Masashi Kato (M)

Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan.

Takafumi Yokomatsu (T)

Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan.

Shinji Miki (S)

Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan.

Takeshi Kimura (T)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH